ROCHESTER–OptimizeRx Corp., which provides digital customer communication services to the pharmaceutical industry, announced plans to acquire RMDY Health, a New York City-based digital therapeutics software-as-a-service platform, for $16 million in cash and equity.

The RMDY Health platform is used by the pharmaceutical industry, payers, medical technology companies and medical associations nationwide.

The acquisition adds three new client segments to OptimizeRx’s existing patient engagement platform – payers, medtech and medical associations – further simplifying chronic disease management and drug adherence for healthier results at lower costs.

To read more, click on